Azurity Can't Duck Bionpharma's Sham Suit Claims
A federal judge has refused to throw out Bionpharma's allegations that Azurity Pharmaceuticals Inc. filed a series of anti-competitive lawsuits over a blood pressure drug, saying it was too early to...To view the full article, register now.
Already a subscriber? Click here to view full article